Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.

Finocchiaro C, Segre O, Fadda M, Monge T, Scigliano M, Schena M, Tinivella M, Tiozzo E, Catalano MG, Pugliese M, Fortunati N, Aragno M, Muzio G, Maggiora M, Oraldi M, Canuto RA.

Br J Nutr. 2012 Jul;108(2):327-33. doi: 10.1017/S0007114511005551. Epub 2011 Nov 25.

2.

What is the clinical usefulness of the metabolic syndrome? The Casale Monferrato study.

Bruno G, Fornengo P, Segre O, Novelli G, Panero F, Perotto M, Zucco C, Bargero G, Cavallo-Perin P.

J Hypertens. 2009 Dec;27(12):2403-8. doi: 10.1097/HJH.0b013e3283310ee5.

PMID:
19738492
3.

C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study.

Bruno G, Fornengo P, Novelli G, Panero F, Perotto M, Segre O, Zucco C, Deambrogio P, Bargero G, Perin PC.

Diabetes. 2009 Apr;58(4):926-33. doi: 10.2337/db08-0900. Epub 2008 Dec 15.

4.

Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients.

Panero F, Novelli G, Zucco C, Fornengo P, Perotto M, Segre O, Grassi G, Cavallo-Perin P, Bruno G.

Diabetes Care. 2009 Feb;32(2):301-5. doi: 10.2337/dc08-1241. Epub 2008 Nov 18.

5.

The impact of diabetes on prescription drug costs: the population-based Turin study.

Bruno G, Karaghiosoff L, Merletti F, Costa G, De Maria M, Panero F, Segre O, Cavallo-Perin P, Gnavi R.

Diabetologia. 2008 May;51(5):795-801. doi: 10.1007/s00125-008-0957-4. Epub 2008 Mar 4.

PMID:
18317724

Supplemental Content

Support Center